About Exome

Exome Asset Management is an innovative asset management company focusing on investing in public markets across the worldwide healthcare industry, including pharmaceuticals, biotechnology, healthcare services, and medical devices.

The firm practices two existing investment strategies: one which invests broadly across worldwide healthcare subsectors and geographies, and another that is a specialized healthcare investment fund emphasized on public company opportunities in emerging markets.

    • Founded in 2018 by Samuel D. Isaly
    • Employs soundly developed investment strategies and a philosophy tested by time
    • Two active investment strategies across worldwide healthcare subsectors and geographies
    • Over $190 million Assets Under Management (AUM)1.

Industry Subsectors

Exome Asset Management’s investment strategies are broadly diversified by geography and subsector.

PHARMACEUTICALS

Companies dedicated to the discovery, development, production and commercialization of drugs and other medications.

BIOTECH

Companies focused on the discovery of new therapeutics, including gene and cell therapy products approaching the market.

LIFE SCIENCE TOOLS

Companies that design, manufacture and distribute instruments, consumables, reagents, and various other life science tools and services.

MEDICAL DEVICES

Companies that develop equipment used to prevent, detect, diagnose or treat an illness or disease.

HEALTHCARE SERVICES

Companies dedicated to facilitating treatment, including by providing care, physical facilities, or the distribution of necessary materials.

OTHER HEALTHCARE

Companies involved with various other aspects of the healthcare industry.

Exome Experts

Exome employs a staff of investment professionals and support staff committed to investing for a healthier world.

Samuel D. Isaly
SDI
Samuel D. Isaly

Managing Partner

Christina Maida
CM
Christina Maida

Investment Analyst & Trader

Wongmo Kang
WK
Wongmo Kang

Investment Analyst

Yiqi Liu
YL
Yiqi Liu

Investment Analyst

Sameh Ahsan
SA
Sameh Ahsan

Investment Analyst

Carlos Godoy
CG
Carlos Godoy

Chief of Staff

Joseph Narvaez
JN
Joseph Narvaez

Chief Technology Officer

Meredith Hagen
MH
Meredith Hagen

Compliance Officer

Alex Forschner
AF
Alex Forschner

Head of Business Development

https://www.exomeasset.com/wp-content/uploads/2019/08/first-min.png

2018

Year Founded

100+

Positions Worldwide

$190M+

Assets Under Management1

₁ AUM as of June 30, 2021